Re-defining exacerbations of chronic obstructive pulmonary disease and developing tools to characterise heterogeneity and treatment response by Halner, A

DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection by Halner, A, Hankey, L, Liang, Z, Pozzetti, F, Szulc, D, Mi, E, Liu, G, Kessler, BM, Syed, J, Liu, PJ

Standardisation of clinical assessment, management and follow-up of acute hospitalised exacerbation of COPD: a Europe-wide consensus by Ramakrishnan, S, Janssens, W, Burgel, P-R, Contoli, M, Franssen, FME, Greening, NJ, Greulich, T, Gyselinck, I, Halner, A, Huerta, A, Morgan, RL, Quint, JK, Vanfleteren, LEGW, Vermeersch, K, Watz, H, Bafadhel, M

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial by Ramakrishnan, S, Nicolau, D, Langford, B, Mahdi, M, Jeffers, H, Mwasuku, C, Krassowska, K, Fox, R, Binnian, I, Glover, V, Bright, S, Butler, C, Cane, J, Halner, A, Matthews, P, Donnelly, L, Simpson, J, Baker, J, Fadai, N, Peterson, S, Bengtsson, T, Barnes, P, Russell, R, Bafadhel, M